Viewing Study NCT03815812


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2025-12-26 @ 10:20 PM
Study NCT ID: NCT03815812
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2019-01-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module